Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
Recruiting · NCT07074418 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2 | Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 4 | 2026-09-10 | NCT07074418 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boehringer Ingelheim | 158 |
| Centre Hospitalier Universitaire de Nice | 229 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU Nice - Hôpital Pasteur 2 | Nice | France | 3 |